Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Marcus

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Clinical and Laboratory Haematology|January 1, 1988
Central retinal artery occlusion in homozygous sickle cell (SS) diseaseR E Marcus, J P Bolger, P J Roderick, et al.
Bone Marrow Transplantation|January 1, 1990
Changes in the natural anticoagulants following bone marrow transplantationP L Harper, J Jarvis, I Jennings, et al.
Bone Marrow Transplantation|November 1, 1991
An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autograftsJ Z Wimperis, T P Baglin, R E Marcus, et al.
Transfusion|January 1, 1984
Blood usage in transfusion-dependent patients. A theoretical modelR E Marcus, E R Johnson, M J Thomas, et al.
Journal of Clinical Pathology|December 1, 1989
Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancyT P Baglin, J J Gray, R E Marcus, et al.
Bone Marrow Transplantation|October 1, 1995
The use of non-cryopreserved peripheral blood progenitor cells in autologous transplantationS Ager, P Mahendra, H K Jestice, et al.
Archives of Disease in Childhood|March 1, 1993
Rapid diagnosis of malignancy using flow cytometryD M Williams, S O'Connor, J W Grant, et al.
British Journal of Haematology|July 1, 1993
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpuraS H Lim, G Hale, R E Marcus, et al.
Bone Marrow Transplantation|March 1, 1995
Failure to mobilise and harvest PBPC does not necessarily preclude the use of high-dose therapy and autologous stem cell rescueM A Scott, S Ager, H K Jestice, et al.
Leukemia & Lymphoma|July 27, 2016
High Dose, Short Duration Combination Chemotherapy (MEGA III) for Patients with High Grade Poor Prognosis Non-Hodgkin's Lymphoma-A Phase I/II StudyS H Lim, E M Richards, J Z Wimperis, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Clinical and Laboratory Haematology|January 1, 1988
Central retinal artery occlusion in homozygous sickle cell (SS) diseaseR E Marcus, J P Bolger, P J Roderick, et al.
Bone Marrow Transplantation|January 1, 1990
Changes in the natural anticoagulants following bone marrow transplantationP L Harper, J Jarvis, I Jennings, et al.
Bone Marrow Transplantation|November 1, 1991
An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autograftsJ Z Wimperis, T P Baglin, R E Marcus, et al.
Transfusion|January 1, 1984
Blood usage in transfusion-dependent patients. A theoretical modelR E Marcus, E R Johnson, M J Thomas, et al.
Journal of Clinical Pathology|December 1, 1989
Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancyT P Baglin, J J Gray, R E Marcus, et al.
Bone Marrow Transplantation|October 1, 1995
The use of non-cryopreserved peripheral blood progenitor cells in autologous transplantationS Ager, P Mahendra, H K Jestice, et al.
Archives of Disease in Childhood|March 1, 1993
Rapid diagnosis of malignancy using flow cytometryD M Williams, S O'Connor, J W Grant, et al.
British Journal of Haematology|July 1, 1993
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpuraS H Lim, G Hale, R E Marcus, et al.
Bone Marrow Transplantation|March 1, 1995
Failure to mobilise and harvest PBPC does not necessarily preclude the use of high-dose therapy and autologous stem cell rescueM A Scott, S Ager, H K Jestice, et al.
Leukemia & Lymphoma|July 27, 2016
High Dose, Short Duration Combination Chemotherapy (MEGA III) for Patients with High Grade Poor Prognosis Non-Hodgkin's Lymphoma-A Phase I/II StudyS H Lim, E M Richards, J Z Wimperis, et al.
Pageof 13